Drug Type Bispecific antibody |
Synonyms- |
Target |
Mechanism BMP2 inhibitors(Bone morphogenetic protein 2 inhibitors), BMP4 inhibitors(Bone morphogenetic protein-4 ligand inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Barrett Esophagus | Preclinical | CH | Esocap AGStartup | - |